SEC FORM 4
$17,147.70
PTC THERAPEUTICS, INC. (PTCT)
Acquisition (code M) of 435 shares at $39.42 per share.
Reporting Person Boulding Mark Elliott · Officer Title EXEC. VP AND CLO · Transaction Code M
Traded Oct 6, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001578852-26-000024 · filed 2026-10-07 · View filing →